Ranolazine therapy is associated with a reduced new diagnosis of diabetes mellitus in chronic coronary syndrome patients: the results of a real-world analysis of an Italian population

31 August 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in coronary artery disease: from bench to bedside (1) Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by